Claims for Patent: 6,130,057

Summary for Patent: 6,130,057

Title:	Method for differentiating microorganisms in a sample
Abstract:	Culture media for microorganisms containing blood or hemin, particularly Trypticase Soy Agar with blood, and chocolate agar, are combined with known chromogenic substrates to produce chromogenic media. Methods for preparing these chromogenic media include adding chromogenic substrates to the surface of previously prepared media, or incorporating the chromogenic substrate into the media as it is prepared. Methods for distinguishing microorganisms in a sample using these culture media are also described.
Inventor(s):	Gosnell; C. Michael (Fallston, MD), Hughes; Carrie A. (Parkton, MD), Goldenbaum; Paul E. (Hampstead, MD)
Assignee:	Becton, Dickinson and Company (Franklin Lakes, NJ)
Application Number:	09/407,638
Patent Claims:	1. A method for differentiating microorganisms in a sample comprising: (a) growing said microorganisms on a chromogenic indicator medium which comprises: (i) a nutrient containing blood or hemin; and (ii) a chromogen; and (b) detecting a color change among the microorganisms grown. 2. The method according to claim 1 wherein component (i) of said chromogenic indicator medium is Trypticase Soy Agar and Blood. 3. The method according to claim 1 wherein component (i) of said chromogenic indicator medium is chocolate agar. 4. The method according to claim 1 wherein said microorganisms are bacteria. 5. The method according to claim 1 wherein said microorganisms are yeasts. 6. The method according to claim 1 wherein the microorganisms are obtained from a clinical source. 7. The method according to claim 1 wherein the microorganisms are obtained from an industrial source. 8. The method according to claim 1 wherein the microorganisms are obtained from a food source. 9. The method according to claim 1 wherein the chromogen is an X-linked chromogen. 10. The method according to claim 1 wherein the chromogen is a Magenta-linked chromogen. 11. The method according to claim 1 wherein the chromogen is a fluorogenic chromogen. 12. The method according to claim 1 wherein the chromogen has an absorption maximum of between about 400 nm and 800 nm. 13. The method according to claim 11 wherein the chromogen has an absorption maximum of between about 10 nm and 400 nm. 14. The method according to claim 3 wherein the microorganisms are bacteria. 15. The method according to claim 14 wherein the bacteria are obtained from a clinical source. 16. The method according to claim 14 wherein the bacteria are obtained from an industrial source. 17. The method according to claim 14 wherein the bacteria are obtained from a food source. 18. The method according to claim 14 wherein the chromogen is an X-linked chromogen. 19. The method according to claim 14 wherein the chromogen is a Magenta-linked chromogen. 20. The method according to claim 14 wherein the chromogen is a fluorogenic chromogen. 21. The method according to claim 14 wherein the chromogen has an absorption maximum of between about 400 nm and 800 nm. 22. The method according to claim 20 wherein the chromogen has an absorption maximum of between 10 nm and 400 nm. 23. A method for differentiating microorganisms in a sample comprising: a) applying a sample suspected of containing microorganisms of interest to a chromogenic indicator medium comprising (i) a nutrient containing blood or hemin; and (ii) a chromogen; b) incubating the sample for a period sufficient to permit detectable growth; and c) determining the visible presence or absence of microorganisms of interest. 24. The method according to claim 23 wherein component (i) of said chromogenic indicator medium is Trypticase Soy Agar and Blood. 25. The method according to claim 23 wherein component (i) of said chromogenic indicator medium is chocolate agar. 26. The method according to claim 23 wherein said microorganisms are bacteria. 27. The method according to claim 26 wherein said bacteria is Haemophilus influenzae. 28. The method according to claim 23 wherein said microorganisms are yeasts. 29. The method according to claim 23 wherein the microorganisms are obtained from a clinical source. 30. The method according to claim 23 wherein the microorganisms are obtained from an industrial source. 31. The method according to claim 23 wherein the microorganisms are obtained from a food source. 32. The method according to claim 23 wherein the chromogen is an X-linked chromogen. 33. The method according to claim 23 wherein the chromogen is a Magenta-linked chromogen. 34. The method according to claim 33 wherein said Magenta-linked chromogen is Magenta-phosphate. 35. The method according to claim 23 wherein the chromogen is a fluorogenic chromogen. 36. The method according to claim 23 wherein the chromogen has an absorption maximum of between about 400 nm and 800 nm. 37. The method according to claim 35 wherein the chromogen has an absorption maximum of between 10 nm and 400 nm. 38. A method of preparing chromogenic media containing blood or hemin comprising applying a chromogenic substrate to a surface of a previously prepared nutrient media, wherein the chromogenic substrate is carried in a solvent. 39. A method of preparing chromogenic media containing blood or hemin comprising adding a chromogenic substrate to a culture medium when the culture medium is prepared and prior to distribution to plates or tubes.

Details for Patent 6,130,057

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	07/20/1983		2040-01-28